Inclusion criteria as widely used for rheumatoid arthritis clinical trials: Patient eligibility in a Turkish cohort

Abstract

Objective. To identify, the proportion of patients fulfilling the inclusion criteria widely used in most clinical trials for rheumatoid arthritis (RA) - including the recent clinical trials of anti-Tinnor Necrosis Factor a (TNF alpha) agents - in a Turkish cohort.